These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15911704)

  • 41. Reversible sympathetic vasomotor dysfunction in POTS patients.
    Freitas J; Santos R; Azevedo E; Costa O; Carvalho M; de Freitas AF
    Rev Port Cardiol; 2000 Nov; 19(11):1163-70. PubMed ID: 11201632
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of Propranolol, Bisoprolol, and Pyridostigmine for Postural Tachycardia Syndrome: a Randomized Clinical Trial.
    Moon J; Kim DY; Lee WJ; Lee HS; Lim JA; Kim TJ; Jun JS; Park B; Byun JI; Sunwoo JS; Lee ST; Jung KH; Park KI; Jung KY; Kim M; Lee SK; Chu K
    Neurotherapeutics; 2018 Jul; 15(3):785-795. PubMed ID: 29500811
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exercise stress testing in healthy subjects during cholinergic stimulation after a single dose of pyridostigmine.
    Serra SM; Costa RV; Bastos BG; Bousquet Santos K; Ramalho SH; da Nóbrega AC
    Arq Bras Cardiol; 2001 Apr; 76(4):279-84. PubMed ID: 11323731
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Renin-aldosterone paradox and perturbed blood volume regulation underlying postural tachycardia syndrome.
    Raj SR; Biaggioni I; Yamhure PC; Black BK; Paranjape SY; Byrne DW; Robertson D
    Circulation; 2005 Apr; 111(13):1574-82. PubMed ID: 15781744
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of oral buspirone, pyridostigmine, and bethanechol on esophageal function evaluated with combined multichannel esophageal impedance-manometry in healthy volunteers.
    Blonski W; Vela MF; Freeman J; Sharma N; Castell DO
    J Clin Gastroenterol; 2009 Mar; 43(3):253-60. PubMed ID: 18987553
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cholinergic stimulation with pyridostigmine protects against exercise induced myocardial ischaemia.
    Castro RR; Porphirio G; Serra SM; Nóbrega AC
    Heart; 2004 Oct; 90(10):1119-23. PubMed ID: 15367503
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neurocardiogenic syncope coexisting with postural orthostatic tachycardia syndrome in patients suffering from orthostatic intolerance: a combined form of autonomic dysfunction.
    Kanjwal K; Sheikh M; Karabin B; Kanjwal Y; Grubb BP
    Pacing Clin Electrophysiol; 2011 May; 34(5):549-54. PubMed ID: 21208233
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The hemodynamic and neurohumoral phenotype of postural tachycardia syndrome.
    Garland EM; Raj SR; Black BK; Harris PA; Robertson D
    Neurology; 2007 Aug; 69(8):790-8. PubMed ID: 17709712
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical analysis and follow-up study of postural orthostatic tachycardia syndrome in 28 pediatric cases].
    Zhang QY; Du JB; Li WZ
    Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):165-9. PubMed ID: 15833184
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Time-dependent heart rate variability in the head-up tilt test in children with postural orthostatic tachycardia syndrome].
    Ran J; Wang C; Zou RM; Wu LJ; Lin P; Li F; Xu Y
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Oct; 17(10):1070-3. PubMed ID: 26483226
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Altered sympathetic nervous reactivity and norepinephrine transporter expression in patients with postural tachycardia syndrome.
    Lambert E; Eikelis N; Esler M; Dawood T; Schlaich M; Bayles R; Socratous F; Agrotis A; Jennings G; Lambert G; Vaddadi G
    Circ Arrhythm Electrophysiol; 2008 Jun; 1(2):103-9. PubMed ID: 19808400
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Pyridostigmine in the treatment of primary orthostatic hypotension].
    Monge Argiles JA; Leiva Santana C
    Neurologia; 2007 May; 22(4):260-2. PubMed ID: 17492522
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exercise in the postural orthostatic tachycardia syndrome.
    Fu Q; Levine BD
    Auton Neurosci; 2015 Mar; 188():86-9. PubMed ID: 25487551
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acetylcholinesterase Inhibition Attenuates the Development of Hypertension and Inflammation in Spontaneously Hypertensive Rats.
    Lataro RM; Silva CA; Tefé-Silva C; Prado CM; Salgado HC
    Am J Hypertens; 2015 Oct; 28(10):1201-8. PubMed ID: 25758777
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Resting and reflex heart rate responses during cholinergic stimulation with pyridostigmine in humans.
    Nóbrega AC; Carvalho AC; Bastos BG
    Braz J Med Biol Res; 1996 Nov; 29(11):1461-5. PubMed ID: 9196546
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute electrophysiologic consequences of pyridostigmine inhibition of cholinesterase in humans.
    Zimerman LI; Liberman A; Castro RR; Ribeiro JP; Nóbrega AC
    Braz J Med Biol Res; 2010 Feb; 43(2):211-6. PubMed ID: 20084332
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cholinergic stimulation with pyridostigmine blunts the cardiac responses to mental stress.
    Nóbrega AC; Carvalho AC; Santos KB; Soares PP
    Clin Auton Res; 1999 Feb; 9(1):11-6. PubMed ID: 10212743
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of atropine, 2-PAM, or pyridostigmine in euvolemic or hemorrhagic conscious swine.
    Wade CE; Waring PP; Trail DS; Gildengorin VL; Williams BF; Bonner GD
    Mil Med; 1988 Sep; 153(9):470-6. PubMed ID: 3141840
    [No Abstract]   [Full Text] [Related]  

  • 59. Acute effects of oral pyridostigmine on memory and cognitive function in SDAT.
    Molloy DW; Cape RD
    Neurobiol Aging; 1989; 10(2):199-204. PubMed ID: 2657467
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acetylcholinesterase inhibition in the treatment of hypotension.
    Schondorf R
    J Neurol Neurosurg Psychiatry; 2003 Sep; 74(9):1187. PubMed ID: 12933916
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.